Gene Silencing/Gene Editing News on CRISPR, gene editing, RNAi in genetics, genomics, and molecular diagnostics. New CRISPR Approach Enables Gene Editing in Cockroaches, Potentially Many Insect Species The direct parental or DIPA-CRISPR method relies on injecting Cas9 ribonucleoproteins into adult females to introduce mutations into their developing oocytes. Aldevron Gets License From Inscripta to Manufacture, Sell CRISPR Nuclease The nuclease was released by Inscripta in 2017 free of charge to the research community and for single-digit royalties for commercial applications. ERS Genomics Licenses CRISPR-Cas9 IP to Sumitomo Pharma The nonexclusive licensing agreement with the Japanese drugmaker marks the 16th such deal ERS Genomics has signed in Japan. Beyond COVID-19, Proof Dx Plans Infectious Disease, Oncology Tests for CRISPR-Based POC System Premium Proof Diagnostics recently submitted a CRISPR-based, point-of-care test for SARS-COV-2 to the US Food and Drug Administration for Emergency Use Authorization. ERS Genomics Licenses CRISPR IP to Central Institute for Experimental Animals ERS Genomics was founded to provide access to CRISPR-Cas9 intellectual property held by Emmanuelle Charpentier. Apr 4, 2022 Research Groups Modify Gene Editing Tools to Improve Efficiency, Delivery Mar 31, 2022 Myeloid Therapeutics, Prime Medicine Partner on Gene Editing Technology Mar 9, 2022 Key Genes Missing From Christmas Island Rat Genome, Making Resurrection Efforts Difficult Mar 9, 2022 Colossal Biosciences Raises $60M in Series A Round Mar 2, 2022 Engineered Cas9 Enzyme Less Likely to Make Off-Target Cuts, Still Efficient Mar 1, 2022 USPTO Rules in Favor of Broad Institute in CRISPR/Cas9 IP Dispute Feb 17, 2022 Gene Editing Tech Firm Synthego Raises $200M From VC Investors Feb 14, 2022 Base-Editing Sensors Enable High-Throughput Analysis of Cancer-Linked SNVs Feb 10, 2022 Sigma-Aldrich Licenses CRISPR-Cas9 Tech to Horizon Discovery Feb 8, 2022 MilliporeSigma Licenses Sigma-Aldrich CRISPR IP to Agbio Firm BetterSeeds Feb 2, 2022 CRISPR-Cas9 Editing Can Produce Unexpected, Heritable Changes, New Study Finds Jan 25, 2022 Metagenomi Raises $175M in Series B Financing Round Jan 10, 2022 CRISPR-IL Consortium Hopes AI Can Improve Accuracy, Efficiency of Gene Editing Premium Jan 5, 2022 Genetic Medicine Developer SalioGen Therapeutics Raises $115M Dec 30, 2021 Top 10 Articles on GenomeWeb in 2021 Dec 14, 2021 French Plant Breeding Firm Meiogenix Raises $13M in Series A Round Dec 9, 2021 Twin Prime Editing Promises More Precise DNA Changes Without Double-Strand Breaks Nov 17, 2021 Epigenetic Editing Firm Chroma Medicine Launches With $125M in Seed, Series A Financing Nov 10, 2021 Israeli Government Extends CRISPR-IL Consortium With $14.5M in New Funding Oct 25, 2021 Single-Cell Genomics Study Elucidates Viral, Host Factors of Human Cytomegalovirus Load More Breaking News Ancient Genome Sequence Provides Look at Ancestry for Individual Who Perished at Pompeii Allogeneic Stem Cell Transplant Outcomes Improve With Diverse Gut Microbes, Immune Cells CorePath Laboratories, Cizzle Biotechnology Partner on Lung Cancer Blood Test Becton Dickinson Gets CE-IVD Mark for High-Throughput COVID/Flu PCR Test QuantuMDx Obtains CE Mark for 30-Minute Multiplex Respiratory Panel Mitochondrial Protein Resource Reveals New Disease Players The Scan Billion-Dollar Diversity Initiative The Howard Hughes Medical Institute is now accepting applications for its new $1.5 billion initiative to boost the diversity of the scientific workforce. Biotech Co-Founder Arrested A co-founder of a Los Angeles-based biotech company has been arrested in connection with a murder-for-hire scheme, according to Endpoint News. Return of the Tasmanian Tiger The Washington Post reports that a team in Australia is working to bring the thylacine back from extinction. Nature Papers on Genome of Individual From Pompeii, CircRNA Study Best Practices, More In Nature this week: first sequenced genome of a person from Pompeii, best practice guidelines for circRNA studies, and more.